A-186

N/A

Report date: 2024/04/23 15:24:28
NME

Base Information

Drug NameA-186
Drug Alias NameA-186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan Kelun Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKlus Pharma IncShandong Kelun Phaemaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A